Dow Jones

38 686,32

1,51%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

TNOX

Tanox (TNOX)

Tanox (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:TNOX

1 2 3 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
02/08/2007	23h30	PR Newswire (US)	HealthShares(TM) Announces Change to the HealthShares(TM) Respiratory/Pulmonary Index	NASDAQ:TNOX	Tanox (MM)
09/05/2007	23h02	PR Newswire (US)	Tanox Reports 2007 First Quarter Results	NASDAQ:TNOX	Tanox (MM)
15/03/2007	22h53	PR Newswire (US)	Tanox Reports Fourth Quarter and Full Year 2006 Results	NASDAQ:TNOX	Tanox (MM)
29/01/2007	14h36	PR Newswire (US)	Genentech and Tanox Receive 'Second Request' from the Federal Trade Commission	NASDAQ:TNOX	Tanox (MM)
15/01/2007	20h43	PR Newswire (US)	Tanox, Inc. Stockholders Approve Merger With Genentech, Inc.	NASDAQ:TNOX	Tanox (MM)
09/11/2006	23h50	PR Newswire (US)	Genentech Announces Agreement to Acquire Tanox for $20 Per Share	NASDAQ:TNOX	Tanox (MM)
02/11/2006	12h30	PR Newswire (US)	Tanox Reports 2006 Third Quarter Results	NASDAQ:TNOX	Tanox (MM)
25/10/2006	13h00	PR Newswire (US)	Tanox Initiates Phase 1 Clinical Trial Evaluating TNX-650 for Treatment of Asthma	NASDAQ:TNOX	Tanox (MM)
25/10/2006	00h10	PR Newswire (US)	Tanox to Report Third Quarter 2006 Financial Results, Host Conference Call for Investors Nov. 2	NASDAQ:TNOX	Tanox (MM)
14/09/2006	21h03	PR Newswire (US)	Tanox to Present at UBS Global Life Sciences Conference	NASDAQ:TNOX	Tanox (MM)
31/08/2006	14h00	PR Newswire (US)	Tanox to Present at the Bear Stearns Healthcare Conference	NASDAQ:TNOX	Tanox (MM)
17/08/2006	20h00	PR Newswire (US)	New Data Confirm Durable Response of TNX-355 Regimens Through 48 Weeks in Treatment-Experienced HIV Patients	NASDAQ:TNOX	Tanox (MM)
08/08/2006	12h30	PR Newswire (US)	Tanox Reports 2006 Second Quarter Results	NASDAQ:TNOX	Tanox (MM)
04/08/2006	00h45	PR Newswire (US)	Tanox Conducts Meeting With Food and Drug Administration Regarding Its HIV/AIDS Antibody, TNX-355	NASDAQ:TNOX	Tanox (MM)
18/07/2006	15h00	PR Newswire (US)	Tanox to Report Second Quarter 2006 Financial Results, Host Conference Call for Investors Aug. 8	NASDAQ:TNOX	Tanox (MM)
01/06/2006	01h21	PR Newswire (US)	Results of TNX-355 Combination Study Published in Antimicrobial Agents and Chemotherapy	NASDAQ:TNOX	Tanox (MM)
23/05/2006	12h00	PR Newswire (US)	First Patient Dosed in Phase 1 Trial of Tanox's TNX-650	NASDAQ:TNOX	Tanox (MM)
02/05/2006	12h00	PR Newswire (US)	Tanox Reports 2006 First Quarter Results	NASDAQ:TNOX	Tanox (MM)
02/05/2006	11h00	PR Newswire (US)	Tanox Reports 48-Week Results From TNX-355 Phase 2 Clinical Trial	NASDAQ:TNOX	Tanox (MM)
17/04/2006	22h30	PR Newswire (US)	Tanox to Present at Two Investor Conferences in May	NASDAQ:TNOX	Tanox (MM)
10/04/2006	19h00	PR Newswire (US)	Tanox to Report First Quarter 2006 Financial Results, Host Conference Call for Investors May 2	NASDAQ:TNOX	Tanox (MM)
28/02/2006	12h30	PR Newswire (US)	Tanox Reports Fourth Quarter and Full Year 2005 Results	NASDAQ:TNOX	Tanox (MM)
09/02/2006	20h00	PR Newswire (US)	New Research Reaffirms Tropism Independence of TNX-355; Data for Tanox's Novel HIV Viral Entry Inhibitor Presented at 2006 CROI	NASDAQ:TNOX	Tanox (MM)
09/02/2006	04h30	PR Newswire (US)	Tanox to Report 2005 Fourth Quarter and Full Year Results Feb. 28	NASDAQ:TNOX	Tanox (MM)
03/02/2006	16h34	PR Newswire (US)	Tanox to Present at Two Investor Conferences in February	NASDAQ:TNOX	Tanox (MM)
23/01/2006	13h00	PR Newswire (US)	Tanox Receives Multimillion Xolair(R) Milestone Payment	NASDAQ:TNOX	Tanox (MM)
04/01/2006	19h29	PR Newswire (US)	Tanox to Present at JP Morgan Healthcare Conference	NASDAQ:TNOX	Tanox (MM)
20/12/2005	20h14	PR Newswire (US)	Tanox Submits Investigational New Drug Application for TNX-650 for Treatment of Hodgkin's Lymphoma	NASDAQ:TNOX	Tanox (MM)
17/12/2005	19h30	PR Newswire (US)	Data Indicates Tanox HIV Drug Candidate Active In Vitro Against CCR5 and CXCR4 Viruses and Synergistic with Entry Inhibitor	NASDAQ:TNOX	Tanox (MM)
17/12/2005	16h30	PR Newswire (US)	Additional Phase 2 Data Supports Further Development of Tanox's Novel HIV Therapy	NASDAQ:TNOX	Tanox (MM)